Target intelligence / Profile preview

Microsomal anti-estrogen binding site (AEBS) (AEBS)

Target
AEBS
Molecular classification
Enzyme, Receptor
01

Overview

The microsomal anti-estrogen binding site (AEBS) is a high-affinity, intracellular protein complex located in the endoplasmic reticulum that binds non-steroidal anti-estrogens and histamine (Brandes et al., 1990, Biochem. Pharmacol.). It has been molecularly identified as the enzyme 3-beta-hydroxysteroid-delta-8,delta-7-isomerase (EBP), which is essential for cholesterol biosynthesis (de Medina et al., 2004, J. Biol. Chem.). Unlike the four classical G protein-coupled histamine receptors (H1-H4), AEBS mediates the effects of intracellular histamine on cell proliferation and differentiation (Silvente-Poirot et al., 2003, Mol. Pharmacol.). Drugs such as Tamoxifen and Tesmilifene (DPPE) target this site, leading to the inhibition of sterol metabolism and the induction of growth arrest in various cancer cell lines (Payre et al., 2008, Mol. Cancer Ther.). This interaction suggests that AEBS serves as a critical link between histamine signaling and the control of cellular growth, making it a significant therapeutic target in oncology (Kedjouar et al., 2004, J. Biol. Chem.). The binding of histamine to AEBS is thought to regulate the production of specific sterols that act as signaling molecules for cell differentiation (de Medina et al., 2011, Proc. Natl. Acad. Sci. USA). Research indicates that AEBS is involved in the mechanism of action of several anti-cancer agents, providing a pathway for inducing cell death independent of the estrogen receptor (Poirot et al., 2012, Biochem. Pharmacol.). Its role in cholesterol homeostasis also links it to potential metabolic and developmental disorders (Herman, 2003, Am. J. Med. Genet.).

Other names
Anti-estrogen binding siteMicrosomal histamine binding siteHn receptorIntracellular histamine binding site3-beta-hydroxysteroid-delta-8,delta-7-isomeraseEmopamil binding proteinEBP
02

Mechanism of action

Inhibition of the enzyme 3-beta-hydroxysteroid-delta-8,delta-7-isomerase (EBP) and modulation of intracellular histamine signaling to induce cell cycle arrest and apoptosis.

03

Biological functions

Cholesterol biosynthesisCell proliferationCell differentiationSignal transduction
04

Disease associations

CancerInflammation
05

Safety considerations

Disruption of cholesterol homeostasisPotential for ichthyosis or cataracts
06

Interacting drugs

Tamoxifen

3 more in the full profile.

07

Biomarkers

EBP expressionIntracellular histamine levels

Beyond the preview

Go deeper on Microsomal anti-estrogen binding site (AEBS) (AEBS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microsomal anti-estrogen binding site (AEBS) (AEBS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call